Clinical laboratories know full well that patients do not like being stuck by needles. And hospital administrators know that increasing the hospital’s patient-satisfaction scores is important for Medicare hospital accreditation.
This is why hospital administrators are devoting more attention—and budget dollars—to products that have the potential to reduce the pain experienced by patients. And patient satisfaction surveys...
Laboratories in an increasing number of U. S. hospitals and healthcare systems are seeing significantly lower hemolysis rates in the blood specimens their staff are collecting with new technology designed for drawing blood with a single-use, sterile device that advances into the vein through a peripheral IV (PIV).
The technology, PIVO (Velano Vascular, San Francisco, California), is a needle-free blood collection device that attaches to a PIV and is used as an alternative to venipunctures...
How has a health system with a 323-bed hospital and a three-person innovation team built connections with more than 100 startups around the globe and attracted a Johnson & Johnson innovation lab to collocate on its campus? And how does it simultaneously challenge its own academic faculty to tackle the quandary of pediatric device innovation?
San Francisco medical device company Velano Vascular closed a $25 million second round of financing, bringing its total overall to $50 million. The new capital will go toward expanding its needle-less blood draw device and to developing new technologies.
CEO Eric Stone would not reveal what these new technologies will entail but said they will fall within the company’s mission of reducing the costs and risk of infections associated with blood draws.
For most of us, getting blood drawn is an unpleasant, but necessary, part of life. For others, though, it's extremely risky, if not impossible. Those people have what is known as difficult venous access (DVA), and they can include children, people witjh chronic illnesses, the elderly and people with diabetes, among others.
Velano Vascular is a company that has developed a way to draw blood in the hospital that isn't invasive; rather than using a needle, Velano's technology, called PIVO, allows practitioners to use the peripheral IV...
Velano Vascular has closed on $25 million in funding that will help the company advance its goal of transforming how blood is drawn from hospital patients.
The company’s chief product is called the PIVO. The FDA-approved device allows providers to draw blood through an already-inserted catheter rather than use a fresh needle.
Vascular access technology pioneer Velano Vascular today announced that it has closed the second tranche of a $25 million growth financing that will fuel commercialization and the launch of additional novel inpatient medical device solutions. This new investment builds on an initial tranche closed in the first half of 2019 and brings Velano’s total funding to more than $50 million...
A small piece of plastic that Centura Health has rolled out to all of its Colorado hospitals is expected to not only make the patient experience better but improve the safety of patients and staff.
The PIVO is a device manufactured by San Francisco-based Velano Vascular. It’s a needle-free, single-use device that connects to a patient’s intravenous line.